在患有慢性阻塞性肺病的患者中坚持吸入器械
Luis Fernando Valladales-Restrepo1,2,3, María Camila Oyuela-Gutiérrez3, Ana Camila Delgado-Araujo1
1Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira-Audifarma S.A, Pereira, Risaralda, Colombia.
Patient preference and adherence
|December 13, 2023
概括
哥伦比亚的慢性阻塞性肺病 (COPD) 患者对吸入治疗的坚持是中等的. 专家培训和患者满意度显著改善了对COPD药物的坚持.
科学领域:
- 肺部医学 肺部医学
- 临床药房 临床药房
- 公共卫生 公共卫生
背景情况:
- 慢性阻塞性肺病 (COPD) 影响全球数以百万计的人,治疗不坚持恶化了结果.
- 改善患者对吸入疗法的坚持是控制COPD严重程度,发病率和死亡率的关键.
研究的目的:
- 评估哥伦比亚被诊断患有COPD的患者对他们的处方吸入装置的坚持.
- 确定与吸入性COPD治疗的良好和不良坚持相关的因素.
主要方法:
- 在哥伦比亚84个城市进行了一项横截面研究,涉及哥伦比亚84个城市500名COPD患者.
- 使用TAI-10仪器测量吸入装置的粘附性,得分为50表示粘附性良好.
- 统计分析确定了与遵守相关的因素,包括医生培训,设备使用时间,药物类型,患者满意度,地理区域,疾病持续时间和并发症.
主要成果:
- 吸入性COPD治疗的整体坚持是中度的 (56.6%的良好坚持),平均得分为47.4±5.3.3.
- 积极与良好的粘附相关的因素包括专家医生的培训,使用吸入器不到一年,使用短效β2-上腺激动剂,以及对设备的更高满意度.
- 在中部地区的患者,不到5年的COPD患者和糖尿病患者中观察到较低的坚持.
结论:
- 在研究的COPD患者群体中,吸入式支气管扩展剂和葡萄糖皮质激素的坚持并不是最佳的.
- 根据使用的吸入装置类型,没有发现依附度的显著差异.
- 患者满意度和专家医生提供的培训成为积极影响COPD吸入疗法的关键因素.
相关概念视频
Inhaled Medications
279
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
279
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.9K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.9K
COPD: Management Using Bronchodilators and Corticosteroids
213
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
213
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K


